Yes, in 2026, Health Canada has so far approved two generic semaglutide products for the treatment of type 2 diabetes
Regular physical activity, balanced nutrition, adequate sleep, stress management, and maintaining a healthy body composition all support healthier metabolism
Low blood sugar (hypoglycemia): Both medications can cause low blood sugar, especially when used with other diabetes drugs
At room temperature, common airborne contaminants introduced during needle draws
For most Canadians covered by private insurance, the transition to generic semaglutide is expected to occur at the pharmacy level without patient action, with pharmacists dispensing the generic at the next refill unless a physician has specified the brand-name product is medically necessary